13 results
10-Q
2020 Q3
ONCR
Oncorus, Inc.
12 Nov 20
Quarterly report
8:01am
;
developing a sustainable and scalable manufacturing process for ONCR-177 and future product candidates, including establishing and maintaining supply … experience delays in developing a sustainable, reproducible and scalable manufacturing process, or developing or qualifying and validating product
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
marketing approvals for any product candidates for which we complete clinical trials;
developing a sustainable and scalable manufacturing process for ONCR … a sustainable, reproducible and scalable manufacturing process, or developing or qualifying and validating product release assays, other testing
424B4
ONCR
Oncorus, Inc.
2 Oct 20
Prospectus supplement with pricing info
12:00am
a sustainable and scalable manufacturing process for ONCR-177 and future product candidates, including establishing and maintaining supply … that the FDA would accept them or approve our product candidates. We may also experience delays in developing a sustainable, reproducible and scalable
DRS/A
jc9cv vm6n
20 Dec 19
Draft registration statement (amended)
12:00am
424B4
8pziwgb85rrwr
12 Feb 21
Prospectus supplement with pricing info
4:23pm
DRS
gdu5ylw68p62f7gxzj
31 Oct 19
Draft registration statement
12:00am
DRS/A
exgbfe
26 Aug 20
Draft registration statement (amended)
12:00am
S-1
arlhy
11 Sep 20
IPO registration
4:49pm
DRS/A
ekahwky
29 Jul 20
Draft registration statement (amended)
12:00am
DRS
2agnrur4
28 Jan 21
Draft registration statement
12:00am
- Prev
- 1
- Next